A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.

I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

There is zero evidence that ​​semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This ...

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...

GLP-1s, injectable drugs that mimic hormones to reduce blood sugar and promote weight loss, have skyrocketed in popularity.